Traceability key if biosimilars are compete cut costs
MC TV The Evolving Biosimilars’ Landscape Explore the complexities of the biosimilars’ landscape, such as naming, interchangeability and substitution, differences in the manufacturing processes, as well as the approval pathways & FDA guidelines for biologics, including draft guidance on biosimilars. USA-BIO-106112 MC TV The Evolving Biosimilars’ Landscape Explore the complexities of the biosimilars’ landscape, such … Read more